Epitopea Announces License and Research Collaboration Agreement with MSD to Identify Cryptigen™ Tumor-Specific Antigens
Epitopea is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies for use in hard-to-treat cancers by targeting a new class of untapped ...
Science Daily3d
Research achieves gene-editing breakthrough that could improve treatment for liver disease, other disorders
Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...
Armed robbery in Revesby7d
MAGE-4 Drives Tumor Growth, Blocks Antitumor Response
Researchers at Baylor College of Medicine and collaborating institutions discovered in a mouse model of non-small cell lung ...
Precision gene therapy for liver disorders increases number of correctly repaired cells
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
Baylor College of Medicine8d
Repair Drive: Precision gene therapy for liver disorders
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
GEN8d
Macrophages in Newborn, But Not Adult, Mice Help Regenerate Heart Tissue
Understanding why newborns, but not adults, can regenerate the heart could lead to treatments that "reprogram" adult ...